Precision oncology in head and neck cancers: From molecular mechanisms to novel therapeutic strategies

Precision oncology in head and neck cancers: From molecular mechanisms to novel therapeutic strategies

Neck neoplasms encompass a diverse group of malignancies, including head and neck squamous cell carcinoma (HNSCC), thyroid cancer, salivary gland tumors, and lymphomas. Recent advancements in molecular biology and immunotherapy have revolutionized the treatment landscape for these cancers. Personali...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. Sakthi Sanjana, E. Elizabeth Rani, S. Madhumitha, M. Yuvaraj, E. Karthikeyan
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Series:	Oral Oncology Reports
Subjects:	Neck neoplasms Targeted therapies Immunotherapy Precision medicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772906024005156
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PROTAC-based therapeutics for targeting HPV oncoproteins in head and neck cancers
by: Nobendu Mukerjee, et al.
Published: (2025-12-01)

Cutaneous angiosarcoma of head and neck: Case report and literature review
by: Juliana Maria Rodrigues Sarmento Pinheiro, et al.
Published: (2023-09-01)

The role of flow cytometry for the timely diagnosis of lymphoma in the head and neck district
by: Silvia Bellesi, et al.
Published: (2023-06-01)

Virotherapy in Head and Neck Cancer
by: Zhan Wang
Published: (2024-03-01)

Mandible reconstruction after head and neck management for oral cancer: A case report and literature review
by: Sylvio Luiz Costa De-Moraes, et al.
Published: (2024-06-01)

Development and validation of the modified index of fragility in head and neck cancer surgery
by: Koorosh Semsar-Kazerooni, et al.
Published: (2023-01-01)

Paradigm shift in head and neck oncology patient management
by: Chiquit van Linden van den Heuvell, et al.
Published: (2017-09-01)

Revealing the causal role of immune cells in malignant neoplasms of the head and neck: insights from Mendelian randomization
by: En Zhou, et al.
Published: (2024-11-01)

“Clinicoradiological versus pathological neck staging in locally advanced oral cavity cancers”
by: Jyoti Sharma, et al.
Published: (2023-09-01)

Antifungal effect of atorvastatin in comparison with fluconazole on Candida species isolated from patients undergoing head-and-neck radiotherapy
Published: (2024-12-01)

Change in Pattern of Head and Neck Lesions Diagnosed by FNAC in the Post-COVID-19 Period: Are Lymphoproliferative Disorders on the Rise?
by: Shiv Kumar, et al.
Published: (2024-11-01)

Pembrolizumab as first-line treatment for recurrent and metastatic head and neck cancer – real-world single-centre data
by: Bogdana Patachi, et al.
Published: (2025-01-01)

Gastric Cancer: Molecular Characterization, Therapeutic Innovations, and Perspectives
by: Emily Tonin da Costa, et al.
Published: (2024-01-01)

Current status of precision oncology in adult glioblastoma
by: Johannes Weller, et al.
Published: (2024-12-01)

Natural killer cell in the development and treatment of head and neck squamous cell carcinoma
by: Lu-Ming WANG, et al.
Published: (2021-02-01)

Precision Medicine for Acute Lymphoblastic Leukemia in Children: A Review
by: Anish Ray, et al.
Published: (2024-10-01)

Melioidosis in the head-and-neck region
by: Santosh Kumar Swain, et al.
Published: (2024-11-01)

Exploring PANoptosis in head and neck cancer: A novel approach to cancer therapy
by: Li Wang, et al.
Published: (2025-01-01)

Phase angle is a predictor of overall 5-year survival after head and neck cancer surgery
by: Neyara dos Santos Oliveira, et al.
Published: (2024-11-01)

The clinical application of artificial intelligence in cancer precision treatment
by: Jinyu Wang, et al.
Published: (2025-01-01)

A time frame evaluation of the oral health-related quality of life among patients with head and neck cancer
by: Raquel D'Aquino Garcia Caminha, et al.
Published: (2024-09-01)

Can acetylcysteine ameliorate cisplatin‐induced toxicities and oxidative stress without decreasing antitumor efficacy? A randomized, double‐blind, placebo‐controlled trial involving patients with head and neck cancer
by: Marília B. Visacri, et al.
Published: (2019-05-01)

A qualitative exploration of the pathway to diagnosis and treatment of cutaneous squamous cell carcinoma of the head and neck with perineural spread
by: Poorva Pradhan, et al.
Published: (2024-08-01)

Association of Treatment Delays with Survival for Patients with Head and Neck Cancer Undergoing Surgery and Radiotherapy at the Philippine General Hospital
by: Nicole Sacayan-Quitay, et al.
Published: (2024-11-01)

MICROSURGICAL AUTOGRAFTING FOR RECONSTRUCTION OF HEAD AND NECK ONCOLOGICAL DEFECTS. AN ANALYSIS OF 60 CASES
by: A. V. Karpenko, et al.
Published: (2018-01-01)

Clinical utility of comprehensive genomic profiling for skin cancer: A cohort study of 522 cases in a Japanese real-world setting
by: Okuto Iwasawa, et al.
Published: (2024-12-01)

Identification of a potential prognostic panel of biomarkers for stratification of head and neck squamous cell carcinoma based on HPV status and TP53 mutational status
by: Oriana Barros, et al.
Published: (2023-03-01)

Understanding the tumor microenvironment for personalized immunotherapy in early-onset head and neck squamous cell carcinoma
by: Yidan Shan, et al.
Published: (2025-01-01)

Progress in molecular pathology and targeted therapy of pulmonary sacromatiod carcinoma
by: Yu-Wei DING, et al.
Published: (2021-04-01)

Brazilian Society of Surgical Oncology (BSSO) considerations on head and neck cancer during COVID-19 pandemic
by: Terence Pires de Farias, et al.
Published: (2020-01-01)

Integrative analysis of ASXL family genes reveals ASXL2 as an immunoregulatory molecule in head and neck squamous cell carcinoma
by: Qian Liu, et al.
Published: (2024-12-01)

An Open‐Label Phase II Trial of Pembrolizumab, an Immune Checkpoint Inhibitor Alone or in Combination With Oral Azacitidine as Second‐Line Therapy for Advanced Head and Neck Squamous Cell Cancers
by: Vinod K. Ramani, et al.
Published: (2025-01-01)

Characterization of Metabolic Reprogramming in Head and Neck Squamous Cell Carcinoma and Application Prospects for Targeted Therapy
by: Ruilin WANG, et al.
Published: (2024-12-01)

Unmasking disparities: Head and neck cancer in underserved communities of northern Greece. A hospital-based audit and viewpoint
by: Dimitris Tatsis, et al.
Published: (2024-03-01)

Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors
by: Cassie Pan, et al.
Published: (2024-11-01)

Individualized treatment recommendations for patients with locally advanced head and neck squamous cell carcinoma utilizing deep learning
by: Linmei Zhang, et al.
Published: (2025-01-01)

Textbook of Head and Neck Anatomy /
by: Hiatt, James L., 1934-
Published: (2002)

Mucormycosis of the head and neck
by: Santosh Kumar Swain, et al.
Published: (2018-01-01)

Salvage chemotherapy after progression on immunotherapy in recurrent/metastatic squamous cell head and neck carcinoma
by: Sandra Llop, et al.
Published: (2024-11-01)

Evaluation of Head and Neck Lymphadenopathies in Childhood
by: Elif Sinem Yazıcı, et al.
Published: (2024-01-01)